New research suggests an experimental vaccine could provide new hope for women diagnosed with an aggressive, hard-to-treat ...

An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, ...

THURSDAY, Nov. 14, 2024 (HealthDay News) -- Neoantigen DNA vaccines are safe and capable of inducing neoantigen-specific ...

Immutep's INSIGHT-003 Phase 1 trial reports promising survival data for 1L NSCLC treatment using eftilagimod alpha, Keytruda, ...

A new vaccine that targets an aggressive form of breast cancer is showing promising results in early trials.The vaccine – ...

An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, ...

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an ...

Media ReleaseMature data in patients with a minimum follow-up of 22 months (N=21) shows excellent results, well above historical controls and ...

Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”) announced today that it has regained compliance with Nasdaq for continued listing and that its stock will continue to trade on The ...

Breast cancer patients have been given fresh hope after a new vaccine showed "promise" in treating an aggressive form of the ...

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.

A groundbreaking treatment has been announced for women with an extremely aggressive form of breast cancer. Siteman Cancer ...